| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 41,850 | 35,177 | 24,667 | 30,401 | | Cost of Revenue | 21,644 | 20,051 | 17,674 | 29,383 | | | Gross Profit | 20,206 | 15,126 | 6,993 | 1,018 | | | Operating Expenses | | Research Development | 11,841 | 12,436 | 16,556 | 23,614 | | Selling General and Administrative | 8,641 | 10,083 | 11,120 | 13,092 | | Non Recurring | 423 | (540) | 3,315 | 15,446 | | Others | 2,664 | 4,111 | 4,446 | 4,446 | | | | Total Operating Expenses | 23,569 | 26,090 | 35,437 | 56,598 | | | | Operating Income or Loss | (3,363) | (10,964) | (28,444) | (55,580) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,431 | 3,548 | 2,530 | 2,156 | | Earnings Before Interest And Taxes | (1,932) | (7,416) | (25,914) | (53,424) | | Interest Expense | 1,215 | 2,273 | 1,708 | 1,057 | | Income Before Tax | (3,147) | (9,689) | (27,622) | (54,481) | | Income Tax Expense | 47 | (72) | 197 | 65 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,569) | (9,617) | (27,819) | (54,546) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,194) | (9,617) | (27,819) | (54,546) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,194) | ($9,617) | ($27,819) | ($54,546) |
|
0.38% Nasdaq 
Income Statement
